Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In scientific literature, tirzepatide is recognized as a first-in-class dual incretin receptor agonist designed to harness the complementary effects of both incretin hormones while incorporating structural modifications (fatty acid moiety) that extend its half-life through albumin binding
Weight loss outcomes Clinical trials show Zepbound users achieve greater average weight loss (up to ~22%) compared with Mounjaro users (~15%), reflecting its weight-focused dosing protocols
Separated abdominal muscles and loose skin on the lower abdomen are common side effects during and after pregnancy
Cejka, P
US$ 22.99
US$ 26.63
US$ 29.88
US$ 21.91
US$ 20.52
US$ 24.76
